Other
Gastric Emptying
0
Pipeline Programs↗
1
Active Trials↗
8
Companies Involved↗
Gastric Emptying is an early-stage landscape with 0 programs across 8 companies. The most active players are GSK, Novo Nordisk, Takeda.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
28
clinical trials
Completed24 · 86%
Unknown status2 · 7%
Terminated1 · 4%
Not yet recruiting1 · 4%
Clinical Trials
Trial Activity
28 trials
Gastric Emptying With Metoclopramide in GLP-1 Agonist Patients Undergoing Elective Surgery
Not yet recruiting·—·Phase 4·NCT07100691·80 enrolled
Page 1 of 2
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)